Site icon Research IP

Ausbil Global SmallCap Fund – Research Report 2024

The Ausbil Global SmallCap Fund has retained a “4 IP” rating from Research IP, with a score of 4.20/5.

The Ausbil Global SmallCap Fund provides exposure to an actively managed portfolio, predominantly made up of listed global small capitalised equities, which are primarily selected from the MSCI World Small Cap Index constituents.

What is the Fund’s competitive advantage?

Qualitative Research Report and Data Tear Sheet

Looking for some quick access key facts about the fund, have a look at our new RIPPL Effect report, designed to be read in conjunction with the qualitative research.
The full research report and data tear sheet can be accessed by subscribing for FREE to the Research IP Tools page.

Research IP says

“The Manager demonstrates a repeatable investment process which provides access for investors seeking stocks with unrecognised growth characteristics in the global small cap space. Quantitative tools are used as a complement to keep the process consistent.”

“The Manager has four stages to the investment process. The process is well defined, although the Manager is alert to learnings and potential improvements to the process in practice. Research IP believes this is a crucial aspect to investing generally, let alone in global small cap stocks.”

“Small caps are naturally less liquid than large cap stocks in the global universe, however Research IP believes the Manager has the necessary settings in place to measure and monitor liquidity risk in the portfolio. Management of liquidity risk is built into the Manager’s investment process through weighting stocks in the portfolio by liquidity (average daily trading volume over the last 3 months) rather than investment preference.“

Research IP, 27 March 2024

If you have any questions in relation to this report or the Research IP services, please contact us here.

Disclaimer, Disclosures and Warnings
Research IP strongly recommends this document and report be read in conjunction with the relevant Product Disclosure Statement. Research IP gives no warranty of accuracy or completeness of information in this document. Any information, opinions, views, or recommendations are general information only and do not take into consideration any person’s particular financial situation or goals and therefore do not constitute financial advice. This document should not be relied upon as a substitute for financial advice from your financial adviser.


Exit mobile version